May 20, 2009 | NEWS
Underscores quality of deCODE’s laboratory and tests, fulfilling key federal and state certification requirements and broadening marketing channels Reykjavik, ICELAND, May 20, 2009 – deCODE genetics (Nasdaq:DCGN) today announced that its CLIA-registered DNA isolation...
May 17, 2009 | NEWS
Reykjavik, ICELAND, May 17, 2009 – In a paper published today in the online edition of Nature Genetics, scientists from deCODE genetics (Nasdaq:DCGN) and academic colleagues from Iceland, Denmark and the Netherlands present the discovery of single letter variations in...
Apr 23, 2009 | NEWS
Reykjavik, ICELAND, and Alameda, CA – April 23, 2009 – deCODE genetics (NASDAQ:DCGN) and Celera Corporation (NASDAQ:CRA) today announced the signing of agreements under which deCODE has granted Celera non-exclusive worldwide licenses to deCODE’s genetic markers...
Feb 19, 2009 | NEWS
Californians can now enjoy the benefits of deCODE’s market-leading DNA-based disease risk assessment tests and pioneering deCODEme™ genome scans Reykjavik, ICELAND, February 19, 2009 – deCODE genetics (Nasdaq:DCGN) today announced that it has received a clinical...
Feb 9, 2009 | NEWS
Genetic variants influencing white blood cell counts are linked to increased risk of heart attack and asthma; variants are being integrated into deCODEme™ Reykjavik, ICELAND, February 9, 2009 – In a paper published today, scientists at deCODE genetics (Nasdaq:DCGN)...
Feb 6, 2009 | NEWS
Reykjavik, ICELAND, February 6, 2009 – Scientists at deCODE genetics (Nasdaq:DCGN) today present the discovery of two single letter variations in the sequence of the human genome (SNPs) conferring substantial increased risk of thyroid cancer. The two SNPs, located on...
